We are live on ! Find out more
HSCS icon

Heart Test Laboratories

10 hedge funds and large institutions have $610K invested in Heart Test Laboratories in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less capital invested

Capital invested by funds: $612K → $610K (-$1.38K)

0.4% less ownership

Funds ownership: 6.62%6.21% (-0.4%)

17% less funds holding

Funds holding: 1210 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

HSCS Hedge Fund Activity: Q4 2025 in Review

10 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q4 2025, worth a combined $610K — down 0.23% from $612K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of HSCS and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 4 added.

The largest buyer was Geode Capital Management, adding an estimated $42K. The largest seller was Advisory Services Network, exiting entirely with an estimated $35.8K sold.

  • 10 institutional investors held Heart Test Laboratories (HSCS) as of Q4 2025, down from 12 in Q3 2025.
  • Funds reported $610K of Heart Test Laboratories stock for Q4 2025, down 0.23% quarter-over-quarter.
  • 1 fund opened new Heart Test Laboratories positions in Q4 2025 and 3 closed out, a net change of -2 holders.
  • The largest Heart Test Laboratories buyer in Q4 2025 was Geode Capital Management, an estimated $42K added.
  • The largest Heart Test Laboratories seller in Q4 2025 was Advisory Services Network, an estimated $35.8K sold.

Based on aggregated 13F filings for Q4 2025.